Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q1 2022 Earnings
ELVN
6
May
Expected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-2.96
-2.16
-1.37
-0.57
Details
Expected EPS
-0.569
Actual EPS
-2.24
Surprise EPS
-1.67
Surprise Percent
+293.67%
Description
Enliven Therapeutics (ELVN) has reported earnings of -2.24 per share for Q1 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login